Skip to content

10-QAccepted May 13, 4:12 PM ET

Acrivon Therapeutics, Inc. 10-Q

ACRVAcrivon Therapeutics, Inc.

Accepted (ET)

4:12 PM

May 13, 2026

Filed

May 13, 2026

Documents

71

Size

7.2 MB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.